I recently saw your post regarding that, and I am impressed. Everyone has a different tolerance, so as long as it doesn’t seem to cause you any issues it should be OK to continue. Just keep an eye out for any signs of cytotoxicity, as those symptoms are typically more long-term side effects.
Good to hear, I was a bit thrown off by that glass jam jar. I’m assuming the poly bag that you store your syringes in is also blackout.
Regarding a viable vehicle, I don’t know. That’s why I said I’d personally try to solubilize in MCT oil, as I’m curious as to what the solubility limit would be. Corn oil is quite a piss-poor oil solvent, and I don’t believe anyone in pharma uses that as a vehicle (not sure why they included it in that paper).
It would have been more helpful if they tried to solubilize in common oily injection vehicles such as grapeseed, cottonseed, or MCT oil, but I suppose I have to find out myself at some point. I am considering compounding some solutions as an experiment, particularly with castor oil which has great sustained-release properties. I cannot deny your argument in favor of injections instead of the oral route, so I would like to help out in that regard since it’s in my field of work. I’m a young scientist, though (in other words, broke), so it may take me a bit to gather the resources.
Interesting that benzyl alcohol can solubilize rapamycin better than DMSO, though! Benzyl alcohol/benzyl benzoate are common preservatives to add to injectable formulations. This makes me think that a blend of 10% DMSO, 10-40% benzyl benzoate/alcohol, and a carrier oil like MCT or castor oil might just work, as I had initially speculated.
At the concentrations you are using (37.5 mg/mL), I think it may be possible to formulate a depot injection, similar to testosterone cypionate. I would have to do a calculation referencing the pKa and pharmacokinetics of rapamycin to estimate how such a depot injection would perform. I’ll definitely keep you posted if I have the time to do it. Quite exciting!
When I stated that it is preferred to be dosed and eliminated quickly, I am referring to the nasty side effects of long-term daily dosing experienced by organ transplants. Namely, hyperglycemia/hypertriglycerimia, weakened immune system, and increased rate of infections.
This is why the weekly/periodic dosing schedule exists - to avoid the side effects while retaining the benefits. The longevity benefits are thought to be due to mTORC1 inhibition, but rapamycin also has the off-target of mTORC2 inhibition, which is the likely model for why the aforementioned side effects occur.
By injecting high-dose rapamycin, you are effectively putting yourself at risk for these side effects. Granted, I agree with you that the weekly oral dosing is suboptimal, and there certainly is a need for better therapies.
I acknowledge that such dosing protocols exist that are comparable to what you are currently doing, but we are not cancer or organ transplant patients. Yes, those patients do take rapamycin for years, but it is quite a miserable experience for a lot of them.
I am in no way disparaging you for what you are doing. I think you’re quite the badass biohacker! I’m just expressing my own concerns over such a therapy as a clinical scientist, but I don’t think the fact that I wear a white labcoat to work should invalidate your approach to your own personal health.
It is indeed interesting that they are rolling out an IV protocol for rapamycin. But keep in mind, IV is fundamentally different from IM. IV is considered a short-release route of administration, while IM is a sustained-release. IM must first diffuse through muscle tissue and then into the bloodstream, while IV just goes directly into the bloodstream. As such, the peak concentration is reached far more quickly in IV, and also gets eliminated that much more quickly than IM.
Furthermore, it seems they are doing one dose per week for two weeks, then one week off. So, in effect, it isn’t that much different from the high-dose weekly protocols that some have on this forum.